These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 21178353)

  • 1. Rapid neurological recovery after intravenous tissue plasminogen activator in stroke: prognostic factors and outcome.
    Machumpurath B; Davis SM; Yan B
    Cerebrovasc Dis; 2011; 31(3):278-83. PubMed ID: 21178353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and outcome of patients with early complete neurological recovery after thrombolysis for acute ischemic stroke.
    Blinzler C; Breuer L; Huttner HB; Schellinger PD; Schwab S; Köhrmann M
    Cerebrovasc Dis; 2011; 31(2):185-90. PubMed ID: 21160181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke.
    Miedema I; Uyttenboogaart M; Koopman K; De Keyser J; Luijckx GJ
    Cerebrovasc Dis; 2010 Feb; 29(3):263-7. PubMed ID: 20090317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and outcome of ischemic stroke patients who are free of symptoms at 24 hours following thrombolysis.
    Strbian D; Sairanen T; Rantanen K; Piironen K; Atula S; Tatlisumak T; Soinne L;
    Cerebrovasc Dis; 2011; 31(1):37-42. PubMed ID: 20980752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolysis at 3-4.5 hours after acute ischemic stroke onset--evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry.
    Shobha N; Buchan AM; Hill MD;
    Cerebrovasc Dis; 2011; 31(3):223-8. PubMed ID: 21178345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Day-90 acute ischemic stroke outcomes can be derived from early functional activity level.
    Ovbiagele B; Saver JL
    Cerebrovasc Dis; 2010; 29(1):50-6. PubMed ID: 19893312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous thrombolysis for acute cerebral ischaemia: comparison of outcomes between patients treated at working versus nonworking hours.
    Bodenant M; Leys D; Debette S; Cordonnier C; Dumont F; Hénon H; Girot M; Lucas C; Devos D; Defebvre L; Deplanque D; Leclerc X; Bordet R
    Cerebrovasc Dis; 2010; 30(2):148-56. PubMed ID: 20551630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy.
    Masrur S; Abdullah AR; Smith EE; Hidalgo R; El-Ghandour A; Rordorf G; Schwamm LH
    J Stroke Cerebrovasc Dis; 2011; 20(2):124-30. PubMed ID: 20598579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced estimated glomerular filtration rate is associated with stroke outcome after intravenous rt-PA: the Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA registry.
    Naganuma M; Koga M; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Okada Y; Hasegawa Y; Kario K; Okuda S; Nishiyama K; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2011; 31(2):123-9. PubMed ID: 21088392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local intra-arterial thrombolysis with urokinase for acute ischemic stroke before and after the approval of intravenous tissue plasminogen activator treatment in Taiwan.
    Yang FC; Lin CC; Hsueh CJ; Lee JT; Hsu CH; Lee KW; Peng GS
    Ann Vasc Surg; 2010 Nov; 24(8):1117-24. PubMed ID: 21035704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Thai patients with acute ischemic stroke after intravenous thrombolysis.
    Dharmasaroja PA; Dharmasaroja P; Muengtaweepongsa S
    J Neurol Sci; 2011 Jan; 300(1-2):74-7. PubMed ID: 20937509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences?
    Allen NB; Myers D; Watanabe E; Dostal J; Sama D; Goldstein LB; Lichtman JH
    Cerebrovasc Dis; 2009; 27(3):254-8. PubMed ID: 19176959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing recovery after acute ischemic stroke with donepezil as an adjuvant therapy to standard medical care: results of a phase IIA clinical trial.
    Barrett KM; Brott TG; Brown RD; Carter RE; Geske JR; Graff-Radford NR; McNeil RB; Meschia JF;
    J Stroke Cerebrovasc Dis; 2011; 20(3):177-82. PubMed ID: 21295494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
    Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
    J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very Early versus Delayed Rehabilitation for Acute Ischemic Stroke Patients with Intravenous Recombinant Tissue Plasminogen Activator: A Nationwide Retrospective Cohort Study.
    Momosaki R; Yasunaga H; Kakuda W; Matsui H; Fushimi K; Abo M
    Cerebrovasc Dis; 2016; 42(1-2):41-8. PubMed ID: 26986718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol adherence and safety of intravenous thrombolysis after telephone consultation with a stroke center.
    Uchino K; Massaro L; Jovin TG; Hammer MD; Wechsler LR
    J Stroke Cerebrovasc Dis; 2010; 19(6):417-23. PubMed ID: 21051004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Can the target group for thrombolysis in acute ischemic stroke be widened? Current indication is very narrow--new study results are necessary].
    Murray V
    Lakartidningen; 2011 Jan 12-18; 108(1-2):16-7. PubMed ID: 21365808
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Cheng JW; Zhang XJ; Cheng LS; Li GY; Zhang LJ; Ji KX; Zhao Q; Bai Y
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):381-390. PubMed ID: 29111341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.